Management of Diabetes During Ramadan

Introduction to GLP-1 Receptor Agonists

The American Diabetes Association recommends GLP-1 receptor agonists as a safe and effective option for diabetic patients fasting during Ramadan, providing glucose control with minimal hypoglycemia risk and typically requiring no dose adjustment 1

The European Association for the Study of Diabetes suggests evaluating hypoglycemia risk stratification and confirming adequate hydration capacity during non-fasting hours, with patients on GLP-1 agonists alone falling into the low-risk category for fasting complications 1
The American College of Cardiology recommends screening for absolute contraindications to fasting, including acute coronary syndrome, advanced heart failure, severe aortic stenosis, poorly controlled arrhythmias, or recent cardiac procedures 2

The American Association of Clinical Endocrinologists advises reducing sulfonylurea dose by at least 50% or discontinuing entirely when combined with GLP-1 receptor agonists during Ramadan to prevent hypoglycemia 3
The International Diabetes Federation recommends adjusting the timing of metformin, with two-thirds of the total daily dose taken immediately before sunset meal and one-third before predawn meal 6, 2

The American Diabetes Association suggests self-monitoring blood glucose closely during the first 3-4 weeks of Ramadan, particularly in the first few hours after starting the fast and in the late afternoon before breaking fast 3, 5
The European Association for the Study of Diabetes recommends breaking the fast immediately if blood glucose drops below 70 mg/dL, and monitoring for dehydration, which can increase thrombotic risk 5, 2
The American College of Cardiology advises against fasting for type 1 diabetes patients, regardless of GLP-1 use, due to high risk for severe hypoglycemia and diabetic ketoacidosis 6, 4, 2

The Academy of Nutrition and Dietetics recommends distributing calories over two to three smaller meals during the non-fasting interval, rather than one large meal at sunset, to prevent postprandial hyperglycemia 2
The American Heart Association advises breaking the fast with a small, balanced meal containing fiber, protein, and complex carbohydrates to avoid rapid eating or overconsumption, and avoiding caffeinated or sugary drinks that increase dehydration risk 1
The American Association of Clinical Endocrinologists warns against assuming all diabetes medications are safe during Ramadan, and against continuing full-dose sulfonylureas when combined with GLP-1 therapy, as this substantially increases severe hypoglycemia risk 6, 3